16006-Lung Cancer-NSCLC-497

Lung Cancer

A Phase II single-arm trial to investigate tepotinib inadvanced (Stage IIIB/IV) non-small cell lung cancerwith MET exon 14 (METex14) skipping alterations or MET amplification(VISION): MS200095-0022

  • Details

ClinicalTrials.gov ID: NCT02864992
Diagnosis Type: NSCLC
USOR Number:

  • Address

1200 Brooklyn Ave, Suite 115
San Antonio, TX 78212
P: (210) 224-6531

Search by practice name, trial titles, indicators and specific disease types.